Applied DNA Sciences (APDN) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Applied DNA Sciences (NASDAQ:APDN) announced its earnings results on Thursday. The technology company reported ($0.11) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.08) by ($0.03), Morningstar.com reports. Applied DNA Sciences had a negative net margin of 299.85% and a negative return on equity of 265.86%. The business had revenue of $0.88 million for the quarter.

NASDAQ:APDN traded down $0.06 during mid-day trading on Friday, hitting $0.45. 4,105 shares of the company’s stock traded hands, compared to its average volume of 810,387. Applied DNA Sciences has a twelve month low of $0.30 and a twelve month high of $1.84. The company has a quick ratio of 1.34, a current ratio of 1.42 and a debt-to-equity ratio of 2.11.

In other news, major shareholder William W. Montgomery acquired 400,000 shares of the business’s stock in a transaction dated Monday, January 7th. The shares were acquired at an average cost of $0.45 per share, with a total value of $180,000.00. Following the completion of the acquisition, the insider now owns 4,560,900 shares of the company’s stock, valued at $2,052,405. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder William W. Montgomery acquired 154,000 shares of the business’s stock in a transaction dated Thursday, January 3rd. The stock was purchased at an average cost of $0.44 per share, for a total transaction of $67,760.00. Following the completion of the acquisition, the insider now directly owns 4,560,900 shares of the company’s stock, valued at approximately $2,006,796. The disclosure for this purchase can be found here. Insiders have purchased a total of 794,000 shares of company stock worth $352,760 over the last ninety days. 21.41% of the stock is currently owned by corporate insiders.



An institutional investor recently raised its position in Applied DNA Sciences stock. Chase Investment Counsel Corp grew its position in Applied DNA Sciences Inc (NASDAQ:APDN) by 99.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 261,163 shares of the technology company’s stock after purchasing an additional 130,000 shares during the period. Chase Investment Counsel Corp owned approximately 0.73% of Applied DNA Sciences worth $104,000 at the end of the most recent quarter. Institutional investors and hedge funds own 6.01% of the company’s stock.

Separately, Maxim Group lowered Applied DNA Sciences from a “buy” rating to a “hold” rating in a research report on Monday, December 31st.

WARNING: This news story was originally posted by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://dakotafinancialnews.com/2019/02/08/applied-dna-sciences-apdn-issues-quarterly-earnings-results-misses-estimates-by-0-03-eps.html.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.

Featured Story: What does cost of debt say about a company’s financial health?

Earnings History for Applied DNA Sciences (NASDAQ:APDN)

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply